Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Medtronic
Dow
Express Scripts
Baxter

Last Updated: March 24, 2023

Patent: 8,112,942


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 8,112,942
Title:Operating room/intervention room
Abstract: A hospital layout comprising a plurality of adjacent OR/intervention rooms (46, 48) uniquely configured and equipped to perform surgical and other interventional procedures, with adjacent intubation rooms (52) configured and equipped to prepare patients for procedures to occur in the OR/intervention rooms and at least one extubation room (54) adjacent the OR/intervention rooms, configured and equipped to post-intervention awaken and extubate patients. A plurality of universal patient rooms (40) are located adjacent the OR/intervention rooms and universal patient rooms, and are configured and equipped to admit patients for surgery/intervention, prepare patients for surgery/intervention, allow patients to recover post-intervention, and discharge patients post-recovery.
Inventor(s): Bohm; Friedrich K. M. (Worthington, OH), Dallam; Richard F (Seattle, WA), Bates; Ernest (San Francisco, CA), Brennan; James V (Columbus, OH), Cini; Ahmet Oktay (Powell, OH), Martin; Wilbur C (Bremerton, WA), Messinger; Corrie E (Galloway, OH), Suen; Hay Mew (Galloway, OH), Williams; Paul L (Orange Beach, AL)
Assignee: NBBJ Design LLP (Seattle, WA)
Application Number:11/129,224
Patent Claims:see list of patent claims

Details for Patent 8,112,942

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live For Injection 125123 05/25/2006 See Plans and Pricing 2024-05-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Baxter
Medtronic
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.